Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Reischl

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Cardiovascular Research|June 21, 2008
The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- miceTanja Schönberger, Dorothea Siegel-Axel, Renate Bussl, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancerAnca-Ligia Grosu, Michael Souvatzoglou, Barbara Röper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
First-in-Humans PET/MRI of In Vivo GD2 Expression in OsteosarcomaNils Florian Trautwein, Gerald Reischl, Christian Seitz, et al.
World Journal of Urology|January 8, 2020
Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancerSascha Kaufmann, Stephan Kruck, Sergios Gatidis, et al.
Diagnostics (Basel, Switzerland)|November 24, 2023
Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT ScannerPia M Linder, Wenhong Lan, Nils F Trautwein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trialStefan Welz, David Mönnich, Christina Pfannenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2019
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer RadiotherapyDaniela Thorwarth, Stefan Welz, David Mönnich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2011
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse modelsDamaris Kukuk, Gerald Reischl, Olivier Raguin, et al.
Physics and Imaging in Radiation Oncology|October 12, 2020
Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapyJairo A Socarrás Fernández, David Mönnich, Sara Leibfarth, et al.
Plos One|April 23, 2015
A Comparative pO2 Probe and [18F]-Fluoro-Azomycinarabino-Furanoside ([18F]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and MuscleMoritz Mahling, Kerstin Fuchs, Wolfgang M Thaiss, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Cardiovascular Research|June 21, 2008
The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- miceTanja Schönberger, Dorothea Siegel-Axel, Renate Bussl, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancerAnca-Ligia Grosu, Michael Souvatzoglou, Barbara Röper, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2022
First-in-Humans PET/MRI of In Vivo GD2 Expression in OsteosarcomaNils Florian Trautwein, Gerald Reischl, Christian Seitz, et al.
World Journal of Urology|January 8, 2020
Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancerSascha Kaufmann, Stephan Kruck, Sergios Gatidis, et al.
Diagnostics (Basel, Switzerland)|November 24, 2023
Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT ScannerPia M Linder, Wenhong Lan, Nils F Trautwein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2017
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trialStefan Welz, David Mönnich, Christina Pfannenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2019
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer RadiotherapyDaniela Thorwarth, Stefan Welz, David Mönnich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2011
Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse modelsDamaris Kukuk, Gerald Reischl, Olivier Raguin, et al.
Physics and Imaging in Radiation Oncology|October 12, 2020
Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapyJairo A Socarrás Fernández, David Mönnich, Sara Leibfarth, et al.
Plos One|April 23, 2015
A Comparative pO2 Probe and [18F]-Fluoro-Azomycinarabino-Furanoside ([18F]FAZA) PET Study Reveals Anesthesia-Induced Impairment of Oxygenation and Perfusion in Tumor and MuscleMoritz Mahling, Kerstin Fuchs, Wolfgang M Thaiss, et al.
Pageof 11